Nanostructured lipid carriers co-delivering lapachone and doxorubicin for overcoming multidrug resistance in breast cancer therapy
Xin Li,1 Xiaoqian Jia,2 Hu Niu2 1Department of Breast and Thyroid Surgery, Heze Municipal Hospital, Heze, Shandong, China; 2Department of General Surgery 2, The Fourth People’s Hospital of Jinan, Jinan, Shandong, China Background: Multidrug resistance is responsible for the poor outcome...
Guardado en:
Autores principales: | Li X, Jia X, Niu H |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c729af607cab47ebb3abc5a25878ee1d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Antineoplastics Encapsulated in Nanostructured Lipid Carriers
por: Gustavo Henrique Rodrigues da Silva, et al.
Publicado: (2021) -
Lymph cancer chemotherapy: delivery of doxorubicin-gemcitabine prodrug and vincristine by nanostructured lipid carriers
por: Ni S, et al.
Publicado: (2017) -
Acute and subacute toxicity profiles of thymoquinone-loaded nanostructured lipid carrier in BALB/c mice
por: Ong YS, et al.
Publicado: (2016) -
Dimeric c(RGD) peptide conjugated nanostructured lipid carriers for efficient delivery of Gambogic acid to breast cancer
por: Kebebe D, et al.
Publicado: (2019) -
Selenium-coated nanostructured lipid carriers used for oral delivery of berberine to accomplish a synergic hypoglycemic effect
por: Yin J, et al.
Publicado: (2017)